FALZONI, Simonetta
 Distribuzione geografica
Continente #
NA - Nord America 9.924
EU - Europa 9.220
AS - Asia 5.467
SA - Sud America 801
AF - Africa 119
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 3
Totale 25.550
Nazione #
US - Stati Uniti d'America 9.710
FI - Finlandia 5.971
SG - Singapore 2.108
CN - Cina 1.360
DE - Germania 1.047
VN - Vietnam 643
BR - Brasile 621
IT - Italia 594
HK - Hong Kong 416
UA - Ucraina 395
GB - Regno Unito 268
TR - Turchia 267
RU - Federazione Russa 232
PL - Polonia 188
FR - Francia 183
JP - Giappone 135
BD - Bangladesh 120
SE - Svezia 108
IN - India 104
CA - Canada 94
MX - Messico 83
ID - Indonesia 82
AR - Argentina 63
NL - Olanda 49
IQ - Iraq 39
ZA - Sudafrica 37
LT - Lituania 35
EC - Ecuador 27
PK - Pakistan 26
ES - Italia 25
BE - Belgio 22
CO - Colombia 21
PH - Filippine 21
UZ - Uzbekistan 21
VE - Venezuela 19
PY - Paraguay 17
SA - Arabia Saudita 17
AT - Austria 16
IE - Irlanda 16
AU - Australia 15
CZ - Repubblica Ceca 12
IL - Israele 12
KE - Kenya 12
MA - Marocco 12
PE - Perù 12
AE - Emirati Arabi Uniti 11
TN - Tunisia 11
CL - Cile 10
EG - Egitto 10
IR - Iran 10
DZ - Algeria 9
LV - Lettonia 9
CR - Costa Rica 8
OM - Oman 8
AZ - Azerbaigian 7
MY - Malesia 7
NP - Nepal 7
PA - Panama 7
BO - Bolivia 6
CH - Svizzera 6
DK - Danimarca 6
JM - Giamaica 6
KR - Corea 6
RO - Romania 6
TH - Thailandia 6
ET - Etiopia 5
JO - Giordania 5
MD - Moldavia 5
PS - Palestinian Territory 5
BG - Bulgaria 4
KZ - Kazakistan 4
LB - Libano 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
AL - Albania 3
AO - Angola 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
DO - Repubblica Dominicana 3
GR - Grecia 3
KG - Kirghizistan 3
MU - Mauritius 3
SN - Senegal 3
TW - Taiwan 3
BH - Bahrain 2
BJ - Benin 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
NG - Nigeria 2
NI - Nicaragua 2
PT - Portogallo 2
QA - Qatar 2
TG - Togo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
Totale 25.533
Città #
Helsinki 5.809
Singapore 1.309
Ashburn 1.202
Fairfield 801
Woodbridge 781
San Jose 733
Houston 494
Chandler 483
Santa Clara 482
Beijing 444
Jacksonville 434
Hong Kong 408
Munich 387
Ann Arbor 354
Seattle 300
Wilmington 273
Ferrara 257
Cambridge 249
Ho Chi Minh City 201
Dallas 195
Warsaw 171
Los Angeles 166
New York 161
Hanoi 156
Izmir 142
Nanjing 133
Tokyo 124
Princeton 112
Addison 106
Lauterbourg 99
San Diego 85
Boardman 80
Shanghai 78
Council Bluffs 61
São Paulo 56
Buffalo 55
Jakarta 54
Turku 54
Mexico City 49
Milan 43
Orem 43
Atlanta 42
Chicago 42
London 42
The Dalles 40
Nanchang 39
Dong Ket 37
Shenyang 37
Da Nang 36
Frankfurt am Main 34
Moscow 34
Bremen 32
Chennai 32
Dearborn 32
Brooklyn 31
Hebei 30
Hefei 30
Montreal 30
Toronto 28
Tianjin 26
Changsha 25
Denver 25
Nuremberg 25
Jiaxing 23
Johannesburg 23
San Francisco 23
Boston 22
Hải Dương 22
Manchester 22
Stockholm 22
Amsterdam 20
Brussels 20
Columbus 20
Tashkent 20
Jinan 19
Phoenix 19
Haiphong 17
Norwalk 17
Baghdad 16
Poplar 16
Rome 16
Rio de Janeiro 15
Bologna 14
Brasília 14
Falkenstein 14
Jyväskylä 14
Ningbo 14
San Mateo 14
Curitiba 13
Guangzhou 13
Philadelphia 13
Augusta 12
Biên Hòa 12
Dhaka 12
Dublin 12
Mountain View 12
Redwood City 12
Salvador 12
Washington 12
Falls Church 11
Totale 18.955
Nome #
A new luciferase target to the extracellular surface of the plasma membrane reveals a new pathway for ATP release in live intact cells. 2.231
A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion 2.159
A new method for measuring local ATP release at the extracellular surface of live intact cells 2.080
A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. 411
Characterization of P2X7 isoform B sheds light on the role of pore versus channel activity in P2X7 mediated life and death. 374
Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7 326
P2X7 targeting inhibits growth of human mesothelioma 303
1513A>C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: Correlation with histological variants and clinical parameters 286
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 279
Amyloid beta-dependent mitochondrial toxicity in mouse microglia requires P2X7 receptor expression and is prevented by nimodipine 266
Extracellular ATP and P2 purinergic signalling in the tumour microenvironment 264
Involvement of the purinergic P2X7 receptor in the formation of multinucleated giant cells 260
The P2X7 receptor directly interacts with the NLRP3 inflammasome scaffold protein 256
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 254
ATP-mediated cytotoxicity in microglial cells 252
P2X7 receptor drives osteoclast fusion by increasing the extracellular adenosine concentration 236
Plasma P2X7 receptor correlation with plasma C-reactive protein in infectious diseases 230
The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination 229
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia 229
ATP receptors and giant cell formation 228
Blockade of P2X7 receptor inhibits formation of multinucleated giant cells. 219
Non-nucleotide agonists triggering P2X7 receptor activation and pore formation 217
ATP secreted by endothelial cells blocks CX 3CL1-elicited natural killer cell chemotaxis and cytotoxicity via P2Y 11 receptor activation 215
The antibiotic polymyxin B modulates P2X7 receptor function 215
Purinoceptor function in the immune system 214
Dysfunctional inflammasome in Schnitzler's syndrome 212
The P2X7 Receptor in Infection and Inflammation 211
The P2X7 receptor is a key modulator of aerobic glycolysis. 209
Synthesis of conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor 205
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia” 201
Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance 201
Mitochondrial P2X7 Receptor Localization Modulates Energy Metabolism Enhancing Physical Performance 200
P2 receptors in cancer progression and metastatic spreading 199
Altered IL-1ß secretion in a patient affected by Schnitzler's syndrome 198
CYTOLYTIC P2X PURINOCEPTORS 193
Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells 191
Hemophagocytic Lymphohistiocytosis in a Patient with Relapsed Chronic Lymphocytic Leukemia Treated with Ibrutinib 189
In-vivo measurement of the extracellular ATP concentration by bio-luminescence: The pmeLUC probe 188
ATP in the tumour microenvironment drives expression of nfP2X(7), a key mediator of cancer cell survival 188
Expression of the P2X7 receptor and metabolic adaptation in serum and glucose deprivation 187
The P2X7 receptor-interleukin-1 liaison 187
Altered IL-1 beta secretion in a patient affected by Schintzler's syndrome 187
Cellular biosensors for the identification of fetal hemoglobin inducers 186
Trophic activity of a naturally occuring isoform of the P2X7 receptor 184
Stable expression in HEK293 cells and characterization of P2X7 isoform B: new hints on P2X7 mediated cell survival. 183
The P2 purinergic receptors of human dendritic cells: Identification and coupling to cytokine release 183
Multiple P2X receptors are involved in the modulation of apoptosis in human mesangial cells: evidence for a role of P2X4 181
The P2X7 Receptor 489C>T Gain of Function Polymorphism Favors HHV-6A Infection and Associates With Female Idiopathic Infertility 181
Extracellular ATP is increased by release of ATP-loaded microparticles triggered by nutrient deprivation 181
High glucose modulates P2X7 receptor-mediated function in human primary fibroblasts 179
P2X7 receptor has a key role in multinucleated giant cells formation. 178
Association of Hypomorphic P2X7 Receptor Genotype With Age 176
The P2X7-inflammasome connection: a novel pathway in autoinflammatory diseases. 171
CHIMERIC PROTEINS FOR MEASURING ATP CONCENTRATIONS IN PERICELLULAR SPACE AND RELATED SCREENING METHOD 171
Role of the purinergic P2Z receptor in spontaneous cell death in j774 macrophage cultures 170
Association of 1513CC P2X7 receptor genotype with age 170
Extarcellular ATP triggers IL-1beta release by activating the purinergic P2Z receptor of human macrophages 169
P2 purinoceptors in the immune system 167
Activation of microglia by amyloid  requires P2X7 receptor expression 166
Use of luciferase probes to measure ATP in living cells and animals 163
P2X7 receptor and polykarion formation 161
The Purinergic P2Z Receptor of Human Macrophage Cells: Characterization and Possible Physiological Role 161
The P2X7 receptor and pannexin-1 are both required for the promotion of multinucleated macrophages by the inflammatory cytokine GM-CSF 161
Role of the P2X7 receptor in in vitro and in vivo glioma tumor growth 161
The P2Z/P2X7 receptor of microglial cells: A novel immunomodulatory receptor 161
The P2X7 receptor for extracellular nucleotides: a novel player in bone remodelling 160
Detecting adenosine triphosphate in the pericellular space 159
Design, synthesis and evaluation in an LPS rodent model of neuroinflammation of a novel 18F-labelled PET tracer targeting P2X7 157
Increased proliferation rate of lymphoid cells transfected with the P2X7 ATP receptor 156
Pharmacological blockade of the P2X7 receptor reverses retinal damage in a rat model of type 1 diabetes 156
Expression and function of the P2X7 receptor in human osteoblasts: The role of NFATc1 transcription factor 156
Signalling by extracellular nucleotides in health and disease 156
P2X7: a novel growth-stimulating receptor in B lymphoblastoid cells 155
The P2X7 receptor sustains the growth of human neuroblastoma cells through a substance P-dependent mechanism 155
Expression of the P2X7 receptor add metabolic adaptation in serum and glucose deprivation 144
P2X7 Receptor Activity Limits Accumulation of T Cells within Tumors 144
Nucleotide receptor: an emerging family of regulatory molecules in blood cells 143
Purinergic signaling in giant cell formation 143
Mouse dendritic cells express the P2X7 purinergic receptor: Characterization and possible participation in antigen presentation 141
Effects of extracellular ATPand adenosine on osteoclast development 139
Dysregulation of P2X7 receptor-inflammasome axis in SAPHO syndrome: successful treatment with anakinra 139
Immunological evidence of an early seroconversion to oncogenic Merkel cell polyomavirus in healthy children and young adults 137
Modulation of Cell Energy Metabolism by the P2X7 Receptor 136
The P2X7 Receptor is a Master Regulator of Microparticle and Mitochondria Exchange in Mouse Microglia 128
Extracellular ATP causes ROCK I-dependent bleb formation in P2X(7)-transfected HEK293 cells 128
Improvement of HSV-1 based amplicon vectors for a safe and long-lasting gene therapy in non-replicating cells 128
Fetal bovine serum contains biologically available ATP 125
Blocking P2X7 by intracerebroventricular injection of P2X7-specific nanobodies reduces stroke lesions 125
Purinergic modulation of interleukin-1β release from microglial cells stimulated with bacterial endotoxin 124
The Coming of Age of the P2X7 Receptor in Diagnostic Medicine 120
The purinergic P2Z receptor is expressed by human macrophages and upregulated by gamma interferon 120
Islet-Derived eATP Fuels Autoreactive CD8+ Cells and Facilitates the Onset of Type 1 Diabetes 119
P2Z purinergic receptor expression correlates with spontaneous cell death of J774 macrophages in vitro 116
Synthesis and biological activity of N-arylpiperazine-modified analogues of KN-62, a potent antagonist of the purinergic P2X(7) receptor 115
Assessing Extracellular ATP as Danger Signal In Vivo: The pmeLuc System 114
Mitochondrial Localization and Function of Adenosine Receptors 114
SCHNITZLER AND SAPHO SYNDROMES: A MOLECULAR LINK BETWEEN P2X7 RECEPTOR AND INFLAMMASOME COMPLEX 113
Human P2X7 isoform B: a trophic receptor 112
Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. 108
The purinergic P2Z receptor is expressed by human macrophages and up-regulated by gamma interferon 98
Totale 24.226
Categoria #
all - tutte 92.741
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.745
Totale 96.486


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021100 0 0 0 0 0 0 0 0 0 0 0 100
2021/20221.136 25 123 56 37 40 35 80 51 29 84 111 465
2022/20231.090 119 66 35 133 183 141 39 127 146 10 65 26
2023/2024711 76 86 33 15 86 108 37 60 16 8 29 157
2024/20253.273 67 78 205 143 335 409 207 214 584 297 385 349
2025/202613.385 876 290 604 925 1.202 469 1.051 453 6.320 823 328 44
Totale 25.775